Feed PPLPHARMA.BO
PP

Piramal Pharma Limited

PPLPHARMA.BO · BSE

₹217.05 +4.40% (+₹9.15)
1M +20.41%
Market Cap ₹277.8B
P/E Ratio 304.83x
Div. Yield -
ROE 1.14%
Valuation
28 /100
Expensive
P/E 304.83x
EV/EBITDA 19.49x
P/S 3.07x
Growth
43 /100
Stable
EPS growth 39.63%
Rev. growth 11.87%
Book val. growth 6.66%
Profitability
39 /100
Moderate
Gross margin 60.58%
Net margin 1.01%
Op. margin 7.49%
Quality
10 /100
Poor
ROIC 1.11%
ROE 1.14%
ROA 0.58%
Debt
56 /100
Moderate
Debt/Equity 0.60x
Current ratio 1.54x
Int. coverage 1.97x
Stability
44 /100
Moderate
Beta 0.32x
Rev. volatility 3.30%
EPS volatility 267.82%
Întreabă StockBot despre PPLPHARMA.BO
Online

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Peter DeYoung

Employees

7,120

Headquarters

Mumbai

Evenimente viitoare

11 NOV.

Earnings

Upcoming earnings report

93d

Folosim cookie-uri esențiale pentru funcționarea site-ului și cookie-uri analitice opționale pentru a măsura utilizarea. Consultați Politica de confidențialitate.